A new study published in the journal Cornea offers important and encouraging findings for families of individuals with Down syndrome and keratoconus, and reinforces why earlier diagnosis matters so much.2 Researchers at Children’s Hospital Colorado examined outcomes in 20 patients with Down syndrome who underwent corneal cross-linking (CXL) under general anesthesia between 2020 and 2024, which is the largest case series of its kind in the United States. General anesthesia is not the typical protocol for CXL. 

What the study found 

The results were encouraging. Cross-linking was well tolerated across all patients, with no serious surgical or anesthesia-related complications. In the months following the procedure, no patient showed meaningful progression of their keratoconus, and none required a corneal transplant during the follow-up period. Among patients who returned for longer-term evaluation, corneal measurements remained stable, which is a meaningful finding for a population in which keratoconus often progresses rapidly and unpredictably. 

There were minor complications in a small number of cases, including temporary corneal swelling that resolved on its own within a few weeks, and one patient who developed new scarring in the year following surgery. These outcomes are consistent with what is seen in the broader population of patients undergoing cross-linking. 

A critical finding about timing 

One aspect of the study that families and caregivers should take seriously: most patients in this study were diagnosed with keratoconus that was already at an advanced stage. In some cases, the disease had progressed to the point where cross-linking was no longer an option. 

This finding reinforces a message that runs through all of NKCF’s work in this area: the window for the most effective intervention is earlier than many families realize. The earlier it is performed, the more vision there is left to protect. 

What this means for families 

This study adds to a growing body of evidence that cross-linking is both safe and effective for individuals with Down syndrome, even when general anesthesia is required. For families navigating this diagnosis, it is an important reminder that treatment is available and that seeking evaluation from a keratoconus specialist sooner rather than later gives the best chance of preserving vision for the long term. 

If your loved one with Down syndrome has not been evaluated for keratoconus or has been diagnosed but not yet discussed treatment options, speaking with a specialist experienced in both keratoconus and the unique needs of individuals with Down syndrome is a meaningful next step.